OncoMatch/Clinical Trials/NCT07708935
Real-World Study of Young Patients With Solid Tumors in China
Is NCT07708935 recruiting? Yes, currently enrolling (Sep 2026).
To evaluate organ preservation rates, fertility preservation, and long-term quality of life after treatment among young patients.
Check if I qualifyExtracted eligibility criteria
Cancer type
Tumor Agnostic
Demographics
Prior therapy
Must have received: antitumor treatment
Patients must have received at least one standard antitumor treatment at a participating study center, including but not limited to curative or palliative surgery, neoadjuvant or adjuvant systemic therapy, and first-line or later-line chemotherapy, targeted therapy, or immunotherapy for advanced disease
Structured fields extracted by AI. May contain errors — verify against the official protocol.
Frequently asked questions
Is NCT07708935 currently recruiting?
Yes, this trial is currently recruiting patients.
Is prior treatment required for enrollment?
Yes. Patients must have previously received antitumor treatment.
Is there an age limit?
Yes. Patients must be 80 years or younger.
Could you qualify for this trial?
Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.
Check if I qualify